An important advisory panel of the American medicine watchdog FDA advised on Thursday evening (Dutch time) to allow a second corona vaccine on an emergency basis to the American market.

It concerns the vaccine from the American company Moderna.

The FDA itself has previously made it clear that it does not see any specific safety concerns.

If they approve it on an emergency basis, the United States will be the first country to use the Moderna vaccine.

This decision is expected to take place on Friday at the latest.

A committee of experts unanimously voted that the benefits of this vaccine outweigh the risks to people over the age of 18.

The US has been hit hard by the corona virus.

On Thursday, the country reported a record number of infections and deaths, 250,000 and 3,700 respectively.

Since the start of the pandemic, more than 300,000 people in the US have died from the effects of the coronavirus.

Both US President Donald Trump and future President Joe Biden see a corona vaccine as a way out of the crisis.

Last week, the FDA already approved the Pfizer / BioNTech vaccine in the US.

Both vaccines that the US is now going to administer have an effectiveness of over 90 percent.

Moderna, like Pfizer, uses the RNA technique.

The vaccine requires two injections, which must be separated by four weeks.

The Netherlands is also entitled to Moderna vaccines through the European Union.

Early next week, the European drug agency EMA will consider this vaccine.

On Thursday, the EMA also brought forward the decision on Moderna's vaccine.

It will now come six days earlier, on January 6.

The EU has ordered 80 million doses, with an option for another 80 million.

Correction: An earlier version of this article stated that just hours after the experts' positive advice, the FDA had officially approved it.

However, this has not yet been disclosed.

The decision is expected to follow later on Friday.

See also: These are the hurdles towards the first vaccination against COVID-19 in the Netherlands